Anxiety, depression, and insomnia symptoms and their key influences during COVID-19 work reopening: A multicenter survey

19.5% to 21.7% of participants reported symptoms of anxiety, depression, or insomnia during the work resumption period of COVID-19.

• 2.9% to 5.6% of participants experienced severe symptoms of anxiety, depression, or insomnia.
• Combined symptoms of anxiety-depression, anxiety-insomnia, or depression-insomnia were reported by 2.4%, 4.8%, and 4.5% of participants, respectively.
• Positive correlations were observed between anxiety and insomnia scores, as well as between depression and insomnia scores.
• Participants aged 50-64 years and those who engaged in outdoor activities at least once in 30 days were identified as risk factors for these psychological symptoms.
• Only 17.4% of participants received psychological interventions during the epidemic, with just 5.2% receiving individual interventions.

Simplified